I. Alex Bowman

2.1k total citations
40 papers, 610 citations indexed

About

I. Alex Bowman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, I. Alex Bowman has authored 40 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in I. Alex Bowman's work include Renal cell carcinoma treatment (24 papers), Cancer Genomics and Diagnostics (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). I. Alex Bowman is often cited by papers focused on Renal cell carcinoma treatment (24 papers), Cancer Genomics and Diagnostics (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). I. Alex Bowman collaborates with scholars based in United States, Canada and Italy. I. Alex Bowman's co-authors include James Brugarolas, Hans J. Hammers, Alana Christie, Raquibul Hannan, Aditya Bagrodia, Kevin D. Courtney, Robert Timmerman, Toni K. Choueiri, Aurélie Garant and Nirmish Singla and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

I. Alex Bowman

39 papers receiving 602 citations

Peers

I. Alex Bowman

PRM

ONCOL

SURGE

Wendong Gu China

Pei Dong China

Raffaele Ratta Italy

Michael Kolinsky Canada

Yunjiang Liu China

Pier Vitale Nuzzo United States

Hualei Gan China

Farhood Alamdari Sweden

Derui Li China

Zhongguo Liang China

Wendong Gu China

I. Alex Bowman

255 ×0.6

PRM

243 ×1.0

ONCOL

283 ×1.4

192 ×1.2

SURGE

272 ×1.9

Citations per year, relative to I. Alex Bowman I. Alex Bowman (= 1×) peers Wendong Gu

Countries citing papers authored by I. Alex Bowman

Since Specialization

Citations

This map shows the geographic impact of I. Alex Bowman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Alex Bowman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Alex Bowman more than expected).

Fields of papers citing papers by I. Alex Bowman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Alex Bowman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Alex Bowman. The network helps show where I. Alex Bowman may publish in the future.

Co-authorship network of co-authors of I. Alex Bowman

This figure shows the co-authorship network connecting the top 25 collaborators of I. Alex Bowman. A scholar is included among the top collaborators of I. Alex Bowman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Alex Bowman. I. Alex Bowman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koshkin, Vadim S., Matthew T. Campbell, Alexandra Drakaki, et al.. (2024). 1967MO Preliminary efficacy and safety of disitamab vedotin (DV) with pembrolizumab (P) in treatment (Tx)-naive HER2-expressing, locally advanced or metastatic urothelial carcinoma (la/mUC): RC48G001 cohort C. Annals of Oncology. 35. S1138–S1139. 11 indexed citations

McCoy, Asia S., et al.. (2024). Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer. Frontiers in Oncology. 14. 1326715–1326715. 13 indexed citations

Aggen, David H., Meredith McKean, Jean Hoffman‐Censits, et al.. (2024). IK-175, an oral AHR inhibitor, as monotherapy and in combination with nivolumab in patients with urothelial carcinoma resistant/refractory to PD-1/L1 inhibitors.. Journal of Clinical Oncology. 42(16_suppl). 2599–2599.

O’Donnell, Peter H., Christopher Hoimes, Jonathan E. Rosenberg, et al.. (2024). Study EV-103: Neoadjuvant treatment with enfortumab vedotin monotherapy in cisplatin-ineligible patients with muscle invasive bladder cancer (MIBC)—2-year event-free survival and safety data for Cohort H.. Journal of Clinical Oncology. 42(16_suppl). 4564–4564. 9 indexed citations

Mulgaonkar, Aditi, Roy Elias, Layton Woolford, et al.. (2022). ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma. Clinical Cancer Research. 28(22). 4907–4916. 10 indexed citations

Hannan, Raquibul, Michael Christensen, Hans J. Hammers, et al.. (2022). Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer. European Urology Oncology. 5(2). 216–224. 43 indexed citations

McKean, Meredith, David H. Aggen, Nehal J. Lakhani, et al.. (2022). Phase 1a/b open-label study of IK-175, an oral AHR inhibitor, alone and in combination with nivolumab in patients with locally advanced or metastatic solid tumors and urothelial carcinoma.. Journal of Clinical Oncology. 40(16_suppl). TPS3169–TPS3169. 8 indexed citations

Hannan, Raquibul, Michael Christensen, Alana Christie, et al.. (2022). Stereotactic Ablative Radiation for Systemic Therapy–naïve Oligometastatic Kidney Cancer. European Urology Oncology. 5(6). 695–703. 33 indexed citations

Reig, Òscar, Akhilesh Mishra, Alana Christie, et al.. (2021). Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma. European Urology. 81(6). 555–558. 9 indexed citations

10.

Patel, A., Jeffrey Howard, Vitaly Margulis, et al.. (2021). Disparities in Pre-Orchiectomy Sperm Cryopreservation Among Testicular Cancer Patients at a Public Safety Net Hospital and a Private Tertiary Care Center. Urology. 163. 126–131. 1 indexed citations

11.

Bhindi, Bimal, Jeffrey Graham, J. Connor Wells, et al.. (2020). Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. European Urology. 78(4). 615–623. 42 indexed citations

12.

Graham, Jeffrey, J. Connor Wells, Frede Donskov, et al.. (2019). Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. European Urology Oncology. 2(6). 643–648. 31 indexed citations

13.

Mulgaonkar, Aditi, Layton Woolford, Kien Nham, et al.. (2019). PD-L1 detection using 89Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response. Journal for ImmunoTherapy of Cancer. 7(1). 144–144. 62 indexed citations

14.

Zhang, Yuanyuan, Jonathan E. Schoenhals, Alana Christie, et al.. (2019). Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(2). 367–375. 68 indexed citations

15.

Singla, Nirmish, Roy Elias, Rashed Ghandour, et al.. (2019). Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 37(12). 924–931. 41 indexed citations

16.

Wardak, Zabi, Alana Christie, I. Alex Bowman, et al.. (2018). Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell Carcinoma. Clinical Genitourinary Cancer. 17(2). e273–e280. 21 indexed citations

17.

Bowman, I. Alex, Alana Christie, Zabi Wardak, et al.. (2018). Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases. Clinical Genitourinary Cancer. 17(2). e263–e272. 18 indexed citations

18.

Bowman, I. Alex, Iván Pedrosa, Payal Kapur, & James Brugarolas. (2017). Renal Cell Carcinoma With Pulmonary Metastasis and Metachronous Non-Small Cell Lung Cancer. Clinical Genitourinary Cancer. 15(4). e675–e680. 6 indexed citations

19.

Bowman, I. Alex, Dan Jones, L. Jeffrey Medeiros, & Rajyalakshmi Luthra. (2004). Quantitative PCR Detection of t(14;18) bcl-2/JH Fusion Sequences in Follicular Lymphoma Patients. Journal of Molecular Diagnostics. 6(4). 396–400. 10 indexed citations

20.

Bowman, I. Alex. (1987). Jean-Baptiste Sénac and his treatise on the heart.. Europe PMC (PubMed Central). 14(1). 5–11. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact